IRF2BP2
Interferon regulatory factor 2-binding protein 2
Also known as: I2BP2_HUMAN, IRF-2BP2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z5L9
- Gene
- IRF2BP2
- Ensembl
- ENSG00000168264
- Chromosome
- 1
- Canonical length
- 587 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes an interferon regulatory factor-2 (IRF2) binding protein that interacts with the C-terminal transcriptional repression domain of IRF2. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
587 residues, UniProt reviewed canonical sequence.
>Q7Z5L9|IRF2BP2
1 MAAAVAVAAA SRRQSCYLCD LPRMPWAMIW DFTEPVCRGC VNYEGADRVE FVIETARQLK
61 RAHGCFPEGR SPPGAAASAA AKPPPLSAKD ILLQQQQQLG HGGPEAAPRA PQALERYPLA
121 AAAERPPRLG SDFGSSRPAA SLAQPPTPQP PPVNGILVPN GFSKLEEPPE LNRQSPNPRR
181 GHAVPPTLVP LMNGSATPLP TALGLGGRAA ASLAAVSGTA AASLGSAQPT DLGAHKRPAS
241 VSSSAAVEHE QREAAAKEKQ PPPPAHRGPA DSLSTAAGAA ELSAEGAGKS RGSGEQDWVN
301 RPKTVRDTLL ALHQHGHSGP FESKFKKEPA LTAGRLLGFE ANGANGSKAV ARTARKRKPS
361 PEPEGEVGPP KINGEAQPWL STSTEGLKIP MTPTSSFVSP PPPTASPHSN RTTPPEAAQN
421 GQSPMAALIL VADNAGGSHA SKDANQVHST TRRNSNSPPS PSSMNQRRLG PREVGGQGAG
481 NTGGLEPVHP ASLPDSSLAT SAPLCCTLCH ERLEDTHFVQ CPSVPSHKFC FPCSRQSIKQ
541 QGASGEVYCP SGEKCPLVGS NVPWAFMQGE IATILAGDVK VKKERDSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IRF2BP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 148 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 148 nTPM
- blood vessel: 69 nTPM
- skin: 60 nTPM
- thyroid gland: 54 nTPM
- endometrium: 52 nTPM
- salivary gland: 52 nTPM
Single-cell type
- epididymal basal cells: 353 nCPM
- gastric progenitor cells: 308 nCPM
- suprabasal keratinocytes: 307 nCPM
- endometrial glandular cells: 305 nCPM
- neutrophil progenitors: 284 nCPM
- basal keratinocytes: 282 nCPM
Immune cell
- plasmacytoid DC: 18 nTPM
- basophil: 10 nTPM
- eosinophil: 8.5 nTPM
- naive CD4 T-cell: 4.9 nTPM
- memory CD4 T-cell: 4.8 nTPM
- myeloid DC: 4.7 nTPM
Brain region
- white matter: 92 nTPM
- medulla oblongata: 85 nTPM
- pons: 77 nTPM
- basal ganglia: 73 nTPM
- midbrain: 73 nTPM
- spinal cord: 72 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IRF2BP2.
Disease | AllUniProt
Conditions IRF2BP2 is implicated in, by any mechanism.
- Immunodeficiency, common variable, 14 (CVID14) MIM:617765
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 810 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Immunodeficiency, common variable, 14
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0.85
- gnomAD missense Z
- 0.62
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- immature B cell differentiation
- negative regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Interferon regulatory factor 2-binding protein 1/2-like, zinc finger
- Interferon regulatory factor 2-binding protein 1/2, C3HC4-type RING finger superfamily
- Interferon regulatory factor 2-binding protein 1/2-like, C3HC4 zinc finger domain
- IRF-2BP1/2-like, middle domain
- Interferon regulatory factor 2-binding protein zinc finger
- IRF-2BP1/2 C3HC4 zinc finger domain
- IRF-2BP1/2 middle domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IRF2BP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IRF2BP2 as an antibody target. Whether an autoantibody or antibody against IRF2BP2 could matter depends on whether native IRF2BP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IRF2BP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label IRF2BP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...